KIORA PHARMACEUTICALS, INC. Common Stock, Capital Shares Reserved for Future Issuance
KIORA PHARMACEUTICALS, INC. (KPRX) had Common Stock, Capital Shares Reserved for Future Issuance of 1.66 million shares as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2022-11-09
- 2022-09-30: Common Stock, Capital Shares Reserved for Future Issuance 1.66M shares.
- 2022-06-30: Common Stock, Capital Shares Reserved for Future Issuance 6.31M shares.
- 2022-03-31: Common Stock, Capital Shares Reserved for Future Issuance 7.16M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2022-09-30 | 1.66M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 6.31M shares 10-Q · filed 2022-08-12 |
| 2022-03-31 | 7.16M shares 10-Q · filed 2022-07-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |